Correlation Between Prime Medicine, and Agilent Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Agilent Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Agilent Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Agilent Technologies, you can compare the effects of market volatilities on Prime Medicine, and Agilent Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Agilent Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Agilent Technologies.

Diversification Opportunities for Prime Medicine, and Agilent Technologies

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Prime and Agilent is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Agilent Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agilent Technologies and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Agilent Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agilent Technologies has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Agilent Technologies go up and down completely randomly.

Pair Corralation between Prime Medicine, and Agilent Technologies

Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Agilent Technologies. In addition to that, Prime Medicine, is 3.24 times more volatile than Agilent Technologies. It trades about -0.26 of its total potential returns per unit of risk. Agilent Technologies is currently generating about 0.16 per unit of volatility. If you would invest  13,386  in Agilent Technologies on September 12, 2024 and sell it today you would earn a total of  733.00  from holding Agilent Technologies or generate 5.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Prime Medicine, Common  vs.  Agilent Technologies

 Performance 
       Timeline  
Prime Medicine, Common 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Etf's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.
Agilent Technologies 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Agilent Technologies are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Agilent Technologies is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Prime Medicine, and Agilent Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prime Medicine, and Agilent Technologies

The main advantage of trading using opposite Prime Medicine, and Agilent Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Agilent Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agilent Technologies will offset losses from the drop in Agilent Technologies' long position.
The idea behind Prime Medicine, Common and Agilent Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world